Drug Profile
Research programme: vitronectin receptor inhibitors
Alternative Names: Vitronectin receptor inhibitors - research programme - WistarLatest Information Update: 23 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malignant melanoma
Most Recent Events
- 17 Feb 2000 New profile
- 17 Feb 2000 Preclinical development for Malignant melanoma in USA (Unknown route)